Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,540 | -6,890 | -3,532 | -12,202 | -10,297 |
| Depreciation Amortization | 53 | 21 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 552 | -120 | -302 | N/A | -140 |
| Other Working Capital | 1,935 | -40 | 799 | -464 | -181 |
| Other Operating Activity | 838 | 943 | 770 | 8,005 | 7,865 |
| Operating Cash Flow | $-8,162 | $-6,086 | $-2,265 | $-4,661 | $-2,753 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -420 | -380 | -180 | 0 | N/A |
| Investing Cash Flow | $-420 | $-380 | $-180 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 12,535 |
| Common Stock Issued | -2,101 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 48,707 | 48,707 | 49,663 | 37,677 | 0 |
| Financing Cash Flow | $46,606 | $48,707 | $49,663 | $37,677 | $12,535 |
| Beginning Cash Position | 33,017 | 33,017 | 33,017 | 1 | 1 |
| End Cash Position | 71,041 | 75,258 | 80,235 | 33,017 | 9,783 |
| Net Cash Flow | $38,024 | $42,241 | $47,218 | $33,016 | $9,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,162 | -6,086 | -2,265 | -4,661 | -2,753 |
| Capital Expenditure | -420 | -380 | -180 | N/A | N/A |
| Free Cash Flow | -8,582 | -6,466 | -2,445 | -4,661 | -2,753 |